Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2010
12/08/2010CN101906151A Specific synthetic polypeptide for detecting novel H1N1 influenza viruses
12/08/2010CN101906150A Preparation method of Bivalirudin
12/08/2010CN101906149A Linear polypeptide and synthetic method and application thereof
12/08/2010CN101906148A Survivin-derived peptides and use thereof
12/08/2010CN101906147A Conjugate formed by two Arg-Gly-Asp-Ser chains and one fatty alcohol chain through Lys, synthesis thereof and application in medicine
12/08/2010CN101906146A Conjugate produced by coupling Arg-Gly-Asp-Ser chain with two fatty alcohol chains through Asp, synthesis of Arg-Gly-Asp-Ser chain and fatty alcohol chains and application in medicine
12/08/2010CN101906145A Conjugate and a synthesis method of two Arg-Gly-Asp-Val chains and fatty alcohol chain through Lys, as well as application in medicine
12/08/2010CN101906144A Conjugate formed by conjugating one Arg-Gly-Asp-Val chain and two fatty alcohol chains by Asp, synthesis thereof and medical application thereof
12/08/2010CN101906143A Conjugate of two Arg-Gly-Asp chains and one fatty alcohol chain through Lys, synthesis and medicine application thereof
12/08/2010CN101906142A Carboline carboxylic acid-tetrapeptide conjugate and synthesis method as well as medical application thereof
12/08/2010CN101906141A Conjugates of one class of peptide chain and double fatty alcohol chains as well as preparation method and application thereof
12/08/2010CN101906140A Aliphatic chain and YIGSR pentapeptide conjugate, and synthesizing method and application thereof
12/08/2010CN101906139A Conjugate of peptide chain, Lys and aliphatic alcohol chain, preparation method and application thereof
12/08/2010CN101906131A Phosphorylation peptide gathering method based on metal hybridization mesoporous material
12/08/2010CN101041907B Compound for Fab fragment of Rituximab and CD20 antigen epitope polypeptide
12/07/2010US7847065 for diagnosis of a colorectal cell proliferative disease; treatment of gastric cancer or colorectal cancer
12/07/2010US7846900 derived from atrial natriuretic peptide prohormone; adenocarcinomas; side effect reduction
12/07/2010US7846895 Selectively/specifically targeted antimicrobial peptide (STAMP) which comprises a targeting peptide and an antimicrobial peptide; "targeted" antibiotic therapies to combat mucosal pathogens with a minimal impact on normal microflora; e.g. peptide G10KHc and a protease inhibitor and/or rhDNase
12/07/2010US7846892 phage-display single chain antibody libraries and screening against amyloid-beta protein, peptide; fusion proteins; kits
12/07/2010US7846710 cell comprising a polypeptide comprising a carboxy-terminal portion of a split intein (C-intein), an amino-terminal portion of a split intein (N-intein), and a target peptide; utilize the trans-splicing ability of split inteins to catalyze cyclization of peptides from a precursor peptide
12/07/2010US7846446 Polypeptide comprising matriptase domain for use in treatment and prevention of ovarian cell proliferative disorders
12/07/2010CA2287505C Inhibitors of cellulolytic, xylanolytic and .beta.-glucanolytic enzymes
12/02/2010WO2010138797A1 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010WO2010137594A1 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
12/02/2010WO2010136831A1 Novel peptides, process for preparation thereof, and use thereof
12/02/2010WO2010136617A1 Polymeric conjugate for treating bacterial infections
12/02/2010US20100306880 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them
12/02/2010US20100305303 Inhibiting agent for inhibition of angiogenesis, a method for preparing the agent, a method for modifying the agent and its use for manufacturing a medicament for treating tumor
12/02/2010US20100305050 Protein product with modified antigenicity
12/02/2010US20100305031 Peptide having an extending action for half-life of object peptide in plasma
12/02/2010US20100305028 Cholesterol derivatives of inhibitors of viral fusion
12/02/2010US20100305027 Cyclic peptides comprising at least one aza-b3-aminoacyl residue and their uses
12/02/2010US20100305026 CD44V6 peptides as inhibitors of bacterial infections
12/02/2010US20100305025 Rnase a peptides, fragments and uses thereof
12/02/2010US20100303842 Peptide analogues
12/02/2010US20100303814 Antibodies Against a Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
12/02/2010US20100303785 Novel therapeutics based on tau/microtubule dynamics
12/02/2010US20100303728 Caspase imaging probes
12/02/2010US20100303727 Optical imaging agents
12/02/2010US20100303724 Polypeptides, Cyclic Polypeptides and Pharmaceutical Comprising Thereof for Non Invasive Specific Imaging of Fibrosis
12/02/2010CA2763685A1 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010CA2763614A1 Iap inhibitors
12/02/2010CA2763395A1 Novel peptides, process for preparation thereof, and use thereof
12/02/2010CA2763327A1 Inhibition 0f inflammation using antagonists of muc1
12/01/2010EP2255832A2 IFBM's to promote attachment of target analytes
12/01/2010EP2254901A1 Therapeutic peptides
12/01/2010EP2254588A2 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN101899098A Cyclic lipopeptide compound Maribasin B and preparation and application thereof
12/01/2010CN101899097A Blood group B epitope mimic peptide and application thereof
12/01/2010CN101899096A Blood group A epitope mimic peptide and application thereof
12/01/2010CN101899095A Centipede toxin anti-tumour active polypeptide
12/01/2010CN101899094A Preparation method of high-purity Daptomycin
12/01/2010CN101899093A X2 polypeptide synthesis product and application thereof.
12/01/2010CN101899092A Novel peptide-link base-conjugate and solid phase synthesis method thereof
12/01/2010CN101899091A Fatty alkyl pentapeptide conjugate, preparation method thereof and application thereof in medical science
12/01/2010CN101897961A Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines
12/01/2010CN101319008B Polypeptide having specific combination with neoplasm metastasis cell and uses thereof
12/01/2010CN101293917B Polypeptide combinative with PKR kinase structure field specificity and uses thereof
12/01/2010CN101190941B Polypeptide with thrombus dissolving activity and its preparation method and application
12/01/2010CN101016332B Short peptide for inhibiting Shiga toxin and application thereof
11/2010
11/30/2010US7842780 Silk fibroin materials and use thereof
11/30/2010US7842671 Blocking cancer cells; antiproliferative agents; inducting apoptosis; anticancer, antitumor agents; peptidomimetics
11/30/2010US7842666 Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration
11/30/2010CA2193969C Peptide, a method of obtaining it and a pharmaceutical compound based on it
11/30/2010CA2144474C Substituted n-ethylglycine derivatives for preparing pna and pna/dna hybrids
11/25/2010WO2010135541A2 Variants of c-type natriuretic peptide
11/25/2010WO2010134537A1 Cell membrane-permeable peptides
11/25/2010WO2010134305A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
11/25/2010WO2010134226A1 Establishment of motif comprising acidic amino acid, capable of stabilizing protein in cells, and applicable to protein therapy, control of differentiation/undifferentiation of cell and antibody therapy
11/25/2010WO2010133806A2 Marked peptides and use thereof for assaying circulating irap
11/25/2010WO2010133367A2 Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
11/25/2010WO2010112713A3 Proteasome-activating lightening peptides and compositions containing same
11/25/2010WO2010112712A3 Novel proteasome-activating anti-aging peptides and compositions containing same
11/25/2010WO2010112711A3 Novel proteasome-activating lightening peptides and compositions containing same
11/25/2010WO2010112710A3 Proteasome-activating anti-aging peptides and compositions containing same
11/25/2010WO2010086294A3 Pan-dr binding polypeptides and uses thereof
11/25/2010WO2010079511A3 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
11/25/2010US20100299769 Novel peptide involved in energy homeostasis
11/25/2010US20100298536 Complex of cell translocational peptide and magnetic nanoparticles and use thereof
11/25/2010US20100298235 Epithelial cell growth promoter
11/25/2010US20100298233 Compositions and methods related to profiling a plurality of cells based on peptide binding
11/25/2010US20100298225 Peptide gap junction modulators
11/25/2010US20100298216 Casein Derived Peptides And Uses Thereof in Therapy
11/25/2010US20100297702 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/25/2010US20100297679 Identification and quantification of biomarkers for evaluating the risk of preterm birth
11/25/2010US20100297664 Paratope and epitope of anti-mortalin antibody
11/25/2010US20100297651 Methods of Modulating Vesicular Trafficking
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297187 Peptide sequences and compositions
11/25/2010US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications
11/25/2010US20100297162 S. epidermidis antigens
11/25/2010US20100297157 Vaccine therapy for choroidal neovascularization
11/25/2010US20100297135 Epitope for neutralizing antibodies
11/25/2010US20100297120 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
11/25/2010US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides
11/25/2010US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same
11/25/2010US20100297071 Immune response inducer
11/25/2010US20100297021 Variants of C-Type Natriuretic Peptide
11/25/2010US20100297017 Method for Synthesizing and Using Pegylated Peptide-Photoactive Chromophore Conjugates and Micellular Formulations Thereof
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 423